Welcome to our dedicated page for Henry Schein SEC filings (Ticker: HSIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Henry Schein’s shifting mix of dental supplies, medical devices, and animal-health vaccines means wading through hundreds of pages of disclosures. Each 10-K bundles segment margins, inventory risk, supplier contracts, and acquisition impacts—details critical if you’re comparing profit drivers across practices. Investors often ask, “Where can I find Henry Schein’s quarterly earnings report 10-Q filing?” or “How do I monitor Henry Schein insider trading Form 4 transactions?” We start by acknowledging that complexity.
Stock Titan’s AI decodes those documents the moment they hit EDGAR. Whether it’s a Henry Schein 8-K material events explained after a sudden product recall, or a Henry Schein proxy statement executive compensation breakdown, our platform translates legal language into clear metrics. You’ll see real-time Henry Schein Form 4 insider transactions—plus alerts when executives buy during tender-offer blackout periods. Need fast trend lines? Our AI stitches together revenue by segment from every Henry Schein quarterly earnings report 10-Q filing and highlights inventory turnover changes.
That means fewer late nights skimming footnotes and more time acting on findings. Use the dashboard to: compare historical cash-flow swings, track Henry Schein executive stock transactions Form 4 against stock performance, or export Henry Schein annual report 10-K simplified summaries for your model. Understanding Henry Schein SEC documents with AI turns filings into actionable context: how private-label margins outweigh branded products, why dental equipment upgrades affect capex, and which acquisitions expand the veterinary line. Visit our dedicated hub for Henry Schein SEC filings explained simply, where insider trades, earnings report filing analysis, and compliance updates arrive automatically.
KKR Group Partnership and affiliated entities reported a significant derivative transaction involving Henry Schein (HSIC) stock. On June 16, 2025, KKR Hawaii Aggregator L.P. executed a total return swap agreement covering 57,348 shares of common stock at a notional price of $71.07 per share.
Key details of the transaction:
- The swap agreement grants KKR Hawaii Aggregator L.P. the right to acquire the shares from the counterparty
- The derivative security is exercisable from June 17, 2025, with an expiration date of July 16, 2027
- Multiple KKR entities are listed as 10% owners, including KKR Group Partnership L.P., KKR & Co., and KKR Management LLP
- Henry Kravis and George Roberts, as founding partners of KKR Management LLP, are indirect beneficial owners
The filing includes disclaimers stating that each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest in the securities.
A Form 4 filing reveals significant derivative transactions by KKR-affiliated entities involving Henry Schein (HSIC) securities. On June 16, 2025, KKR Hawaii Aggregator L.P., a 10% owner, entered into an equity swap transaction covering 57,348 shares of common stock at a notional price of $71.07 per share.
Key details of the derivative transaction:
- Transaction involves an obligation to purchase through an equity swap
- Exercise period: June 17, 2025 to July 16, 2027
- Transaction executed through multiple KKR entities, including KKR Hawaii Aggregator L.P., KKR North America Fund XIII SCSp, and related entities
- Structured as a total return swap with a third-party financial counterparty
The filing includes detailed ownership structure disclosures through various KKR entities, ultimately traced to KKR Management LLP and founding partners Henry R. Kravis and George R. Roberts. All reporting persons have disclaimed beneficial ownership except for their respective pecuniary interests.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What is the primary business of Henry Schein?
How does Henry Schein support its customers?
What distinguishes Henry Schein in the competitive healthcare market?
How does Henry Schein generate its revenue?
What role does technology play in the company’s operations?
How are strategic acquisitions integrated into Henry Schein's business model?
Who are the main customers of Henry Schein?
How does Henry Schein ensure quality and operational efficiency?
